SCCS publishes final Scientific Advice on children’s exposure to Methyl Salicylate (SCCS/1676/25)
Ingredient: Methyl Salicylate

Date of publication: 2 May 2025

The SCCS has revised its scientific advice on children's exposure to Methyl Salicylate, establishing more restrictive concentration limits of 0.4% in toothpaste and 0.02% in other products for children aged 0-3 years, following aggregate exposure considerations from related salicylate assessments.

What’s new?

On 30 April 2025, the Scientific Committee on Consumer Safety (SCCS) adopted a revised Scientific Advice on children’s exposure to Methyl salicylate (methyl 2-hydroxybenzoate). This revision supersedes the previous Scientific Advice SCCS/1654/23 published in September 2023, incorporating new aggregate exposure considerations based on conclusions from the Hexyl Salicylate assessment (SCCS/1658/23).

The revision was specifically requested by the European Commission to re-assess maximum safe concentrations for Methyl Salicylate in products intended for children aged 0-3 years, taking into account potential cumulative exposure from multiple salicylate sources.

Methyl Salicylate is currently regulated under Entry 324 of Annex III to the EU Cosmetics Regulation following its classification as a CMR Category 2 substance (toxic for reproduction). The ingredient functions as a fragrance component, flavoring agent, and soothing agent in cosmetic products, with particular use in oral hygiene formulations.

Main conclusions

Revised concentration limits for children 0-3 years:

  • Maximum 0.4% in toothpaste
  • Maximum 0.02% in all other cosmetic products

What now?

Expected regulatory implementation timeline:

  • Scientific Advice published as final version on 30 April 2025
  • Amendment to Annex III Entry 324 of Cosmetics Regulation is expected
  • Transition periods typically provided for industry compliance (18-24 months)

References

SCCS (Scientific Committee on Consumer Safety), Scientific Advice on Methyl Salicylate (methyl 2-hydroxybenzoate) – children exposure, version of 17 January 2025, final version of 30 April 2025, SCCS/1676/25

Linkedin Instagram Facebook

other REGULATORY UPDATES

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »
Any REGULATORY QUESTION?
E-mail

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »